The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine
Abstract
Full activation of naive CD8 T cells requires Ag, costimulation, and a third signal that can be provided by IL-12. Brief exposure (6 h) to Ag and B7-1 is sufficient to stimulate multiple rounds of cell division, but clonal expansion and development of effector function are minimal even when signal 3 is present. Full activation instead requires concerted signaling by Ag, B7-1, and IL-12 for greater than 40 h. Thus, the gene expression program required for cell division can be initiated by brief interaction with Ag and costimulation, but maintaining the expression of the genes needed for survival and effector function requires prolonged signaling by a signal 3 cytokine in concert with Ag and costimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
T cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,278
Maldonado-López, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., & Moser, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.587 · Cited by 984
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 841
Inflammatory Cytokines Provide a Third Signal for Activation of Naive CD4+ and CD8+ T Cells
Curtsinger, J. M., Schmidt, C. S., Mondino, A., Lins, D. C., Kedl, R. M., Jenkins, M. K., & Mescher, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3256 · Cited by 616
Self-citationThe JAM test A simple assay for DNA fragmentation and cell death
Matzinger, P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90325-a · Cited by 599
Pooley, J. L., Heath, W. R., & Shortman, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5327 · Cited by 588
Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells
Curtsinger, J. M., Lins, D. C., & Mescher, M. F. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021910 · Cited by 509
Self-citationDifferential Production of IL-12, IFN-α, and IFN-γ by Mouse Dendritic Cell Subsets
Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P., & O’Keeffe, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5448 · Cited by 490
Early Programming of T Cell Populations Responding to Bacterial Infection
Mercado, R., Vijh, S., Allen, S. E., Kerksiek, K., Pilip, I. M., & Pamer, E. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6833 · Cited by 477
T cell fitness determined by signal strength
Gett, A. V., Sallusto, F., Lanzavecchia, A., & Geginat, J. (2003) · Nature Immunology · doi:10.1038/ni908 · Cited by 473
Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells
Albert, M. L., Jegathesan, M., & Darnell, R. B. (2001) · Nature Immunology · doi:10.1038/ni722 · Cited by 402
Dynamic programming of CD8+ T lymphocyte responses
van Stipdonk, M. J. B., Hardenberg, G., Bijker, M. S., Lemmens, E. E., Droin, N. M., Green, D. R., & Schoenberger, S. P. (2003) · Nature Immunology · doi:10.1038/ni912 · Cited by 401 · cited 3×
“It appears likely that tolerance will also be the outcome if naive CD8 T cells undergo a brief period of stimulation with Ag, as has been suggested by others (16), even if signal 3 cytokines continue to be present (Fig.”
BackgroundCutting Edge: Antigen-Independent CD8 T Cell Proliferation
Wong, P., & Pamer, E. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5864 · Cited by 269
Coles, R. M., Mueller, S. N., Heath, W. R., Carbone, F. R., & Brooks, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.834 · Cited by 224
The Roles of IL-12 in Providing a Third Signal for Clonal Expansion of Naive CD8 T Cells
Valenzuela, J., Schmidt, C., & Mescher, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6842 · Cited by 193
Self-citationHernández, J., Aung, S., Marquardt, K., & Sherman, L. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011612 · Cited by 136
Schmidt, C. S., & Mescher, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2561 · Cited by 135
Self-citationSchmidt, C. S., & Mescher, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5521 · Cited by 126
Self-citationBevan, M. J., & Fink, P. J. (2001) · Nature Immunology · doi:10.1038/87676 · Cited by 97
Sprent, J. D. (1980) · PubMed · Cited by 26
Cited by
Transcriptional control of effector and memory CD8+ T cell differentiation
Kaech, S. M., & Cui, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3307 · Cited by 1,628
CD4+ T cell help in cancer immunology and immunotherapy
Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M., & Kastenmüller, W. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0044-0 · Cited by 1,585
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
Tay, R. E., Richardson, E. K., & Toh, H. C. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-020-0183-x · Cited by 813
Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates
Sarkar, S., Kalia, V., Haining, W. N., Konieczny, B. T., Subramaniam, S., & Ahmed, R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071641 · Cited by 633
Metadata
- Authors
- Curtsinger, J. M., Johnson, C. M., & Mescher, M. F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11
- Volume
- 171
- Issue
- 10
- Pages
- 5165-5171
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1533714151
- Cited by
- 287
- References
- 21
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.